Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes

Author:

Kaufmann Stefan H. E.1

Affiliation:

1. Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany

Abstract

ABSTRACT A century ago, Emil von Behring passed away. He was the first to be honored by the Nobel Prize for Medicine in 1901 for the successful therapy of diphtheria and tetanus, which he had developed from the bench to the bed. He also contributed to the foundation of immunology, since his therapy was based on passive immunization with specific antisera. Being an ambitious character, he did not shy away from friction with his colleagues Paul Ehrlich and Elias Metchnikoff and his mentor, Robert Koch. Behring was not only an excellent translational researcher but also a successful entrepreneur and early proponent of public-private partnerships.

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Reference15 articles.

1. Über das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren;Behring E;Dtsch Med Wochenschrift,1890

2. Untersuchungen ueber das Zustandekommen der Diphtherie-Immunität bei Thieren;Behring E.;Dtsch Med Wochenschrift,1890

3. Die Geschichte der Diphtherie; mit besonderer Berücksichtigung der Immunitätslehre.

4. Ueber ein neues Diphtherieschutzmittel1)

5. ACTIVE IMMUNITY PRODUCED BY SO CALLED BALANCED OR NEUTRAL MIXTURES OF DIPHTHERIA TOXIN AND ANTITOXIN

Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies in Oral Cancer Therapy;Journal of the Scientific Society;2024-04

2. Two centuries of vaccination: historical and conceptual approach and future perspectives;Frontiers in Public Health;2024-01-09

3. The Potential of Single‐Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics;Journal of Immunology Research;2024-01

4. Soil-Related Bacterial Diseases;Historical Diseases from a Modern Perspective;2024

5. Evidence for the Efficacy of COVID-19 Convalescent Plasma;Current Topics in Microbiology and Immunology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3